相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Delafloxacin: A New Anti-methicillin-resistant Staphylococcus aureus Fluoroquinolone
Louis D. Saravolatz et al.
CLINICAL INFECTIOUS DISEASES (2019)
Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function
Randall K. Hoover et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study
William O'Riordan et al.
CLINICAL INFECTIOUS DISEASES (2018)
Clinical Pharmacokinetics of Sulfobutylether-β-Cyclodextrin in Patients With Varying Degrees of Renal Impairment
Randall K. Hoover et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Pharmacokinetics of Intravenous Delafloxacin in Patients With End-Stage Renal Disease
Randall Hoover et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment
Randall Hoover et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections
Matteo Bassetti et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study
J. Pullman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
In Vitro Activity of Delafloxacin and Microbiological Response against Fluoroquinolone-Susceptible and Nonsusceptible Staphylococcus aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections
S. McCurdy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The Pharmacokinetics of the CYP3A Substrate Midazolam After Steady-state Dosing of Delafloxacin
Susan K. Paulson et al.
CLINICAL THERAPEUTICS (2017)
In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014
M. A. Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin
Jeff Kingsley et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin Resistance
Olusegun O. Soge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Robert K. Flamm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age
Randall Hoover et al.
CLINICAL THERAPEUTICS (2016)
Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers
Randall Hoover et al.
CLINICAL THERAPEUTICS (2016)
Pharmacodynamic and pharmacokinetic profiling of delafloxacin in a murine lung model against community-acquired respiratory tract pathogens
Abrar K. Thabit et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
A Thorough QT Study To Evaluate the Effects of Therapeutic and Supratherapeutic Doses of Delafloxacin on Cardiac Repolarization
Jeffrey S. Litwin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections
William O'Riordan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Disposition, metabolism and mass balance of delafloxacin in healthy human volunteers following intravenous administration
Andrew McEwen et al.
XENOBIOTICA (2015)
Comparison of the Antibiotic Activities of Daptomycin, Vancomycin, and the Investigational Fluoroquinolone Delafloxacin against Biofilms from Staphylococcus aureus Clinical Isolates
Wafi Siala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A Combined Pharmacodynamic Quantitative and Qualitative Model Reveals the Potent Activity of Daptomycin and Delafloxacin against Staphylococcus aureus Biofilms
Julia Bauer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization
Joan M. Remy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin against Staphylococcus aureus
Sandrine Lemaire et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model
AA Firsov et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492
SJ Harnett et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model
SH Zinner et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae
MR Hammerschlag et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
ABT492 and levofloxacin:: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model
AA Firsov et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against gram-positive and gram-negative organisms
LS Almer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro pharmacodynamic activities of ABT-492, a novel quinolone, compared to those of Levofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
SM Gunderson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas
KB Waites et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
分享论文
